Naturally, more work is needed. Although GLS -1 agonists have been used in diabetes for 20 years, some of the newer findings ...

Diamyd Medical provides an update following the receipt of final meeting minutes from a positive Type C meeting with the U.S. Food and Drug Administration ...

Diamyd Medical provides an update following the receipt of final meeting minutes from a positive Type C meeting with the U.S. Food and Drug Administration (FDA) held in December 2024. The meeting ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not ...

A study comparing oral glucose-lowering agents to insulin for gestational diabetes found no non-inferiority in preventing ...

Could an ordinary carrot improve the treatment of type 2 diabetes? A new study from SDU suggests so. The researchers found that carrots can enhance the body's ability to regulate blood sugar and ...

If innovative cancer therapies were the top launches to watch in 2024, this year’s high-profile biopharma debuts is slated to ...

Stanford researchers developed an AI algorithm that identifies Type 2 diabetes subtypes using continuous glucose monitor data ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

Objective To evaluate the association between thyroid disease and diabetes markers. Design Retrospective cohort study. Setting The study was conducted in a diagnostic setting where the primary care ...

The global companion animal diagnostics market is projected to reach US$ 4.55 Billion by 2029 from US$ 2.99 Billion in 2024 ...